To determine whether high levels of APAF1 confer paclitaxel sensitivity to ovarian cancer cells, we transiently transfected SKOV3 and OVCA432 ovarian cancer cells with the full-length APAF1 construct or the control vector pcDNA3.1 and treated them with various concentrations of paclitaxel. This evidence concerns the gene APAF1 and ovarian cancer.